CTSO
Cytosorbents·NASDAQ
--
--(--)
--
--(--)
8.75 / 10
Outperform
Fund flow evaluation: 7.51/10 reflecting robust fund flow characteristics. Constructive Small, Medium, and Large trends face headwinds from adverse overall, block, and Extra-large developments, indicating positive money flow direction. Analyst perspective reveals overwhelmingly bullish analyst consensus with strong conviction. Rating breakdown: Strong Buy(100.0%) from 1 analyst assessments, supported by 10.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-26
InstitutionD. Boral Capital
Times predicted11
Historical Win Rate45.5%
Is money flowing into or out of CTSO?
- CTSO holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 8.75/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
